Back
4D Molecular Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
FDMT
4D Molecular Therapeutics
Last Price:
$4.19
Seasonality Move:
-28.07%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FDMT is experiencing buying pressure, which is a positive indicator for future bullish movement.
4D Molecular Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.3 | Buy |
| 20-day SMA: | 4.14 | Buy |
| 50-day SMA: | 3.9 | Buy |
| 200-day SMA: | 5.46 | Sell |
| 8-day EMA: | 3.72 | Buy |
| 20-day EMA: | 2.37 | Buy |
| 50-day EMA: | 1.18 | Buy |
| 200-day EMA: | 0.33 | Buy |
4D Molecular Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.19 | Buy |
| Relative Strength Index (14 RSI): | 55.54 | Buy |
| Chaikin Money Flow: | 150484 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.98 - 4.38) | Buy |
| Bollinger Bands (100): | (3.2 - 4.3) | Buy |
4D Molecular Therapeutics Technical Analysis
| Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for 4D Molecular Therapeutics Stock
Is 4D Molecular Therapeutics Stock a Buy?
-
4D Molecular Therapeutics share price is 4.36 while FDMT 8-day simple moving average is 4.30, which is a Buy signal.
-
The stock price of FDMT is 4.36 while 4D Molecular Therapeutics 20-day SMA is 4.14, which makes it a Buy.
-
4D Molecular Therapeutics 50-day simple moving average is 3.90 while FDMT share price is 4.36, making it a Buy technically.
-
FDMT stock price is 4.36 and 4D Molecular Therapeutics 200-day simple moving average is 5.46, creating a Sell signal.
FDMT Technical Analysis vs Fundamental Analysis
Sell
37
4D Molecular Therapeutics (FDMT)
is a Sell
Is 4D Molecular Therapeutics a Buy or a Sell?
-
4D Molecular Therapeutics stock is rated a SellThe current 4D Molecular Therapeutics [FDMT] share price is $4.36. The Score for FDMT is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
4D Molecular Therapeutics Stock Info
Market Cap:
202M
Price in USD:
4.36
Share Volume:
275.9K
4D Molecular Therapeutics 52-Week Range
52-Week High:
19.69
52-Week Low:
2.24
Sell
37
4D Molecular Therapeutics (FDMT)
is a Sell
4D Molecular Therapeutics Share Price Forecast
-
What is the 4D Molecular Therapeutics stock price today?The 4D Molecular Therapeutics stock price is 4.36 USD today.
-
Will FDMT stock go up or go down?4D Molecular Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is 4D Molecular Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, 4D Molecular Therapeutics is overvalued.
Is 4D Molecular Therapeutics Stock a Buy?
-
4D Molecular Therapeutics share price is 4.36 while FDMT 8-day exponential moving average is 3.72, which is a Buy signal.
-
The stock price of FDMT is 4.36 while 4D Molecular Therapeutics 20-day EMA is 2.37, which makes it a Buy.
-
4D Molecular Therapeutics 50-day exponential moving average is 1.18 while FDMT share price is 4.36, making it a Buy technically.
-
FDMT stock price is 4.36 and 4D Molecular Therapeutics 200-day simple moving average is 0.33, creating a Buy signal.
Fundamental Analysis of 4D Molecular Therapeutics
Is 4D Molecular Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.28 per share.
Technical Analysis of 4D Molecular Therapeutics
Should I short 4D Molecular Therapeutics stock?
-
FDMT Moving Average Covergence Divergence (MACD) indicator is 1.19, suggesting 4D Molecular Therapeutics is a Buy
-
4D Molecular Therapeutics Relative Strength Index (RSI) is 55.54, which suggest 4D Molecular Therapeutics is overbought
-
The Bollinger Bands (25) for 4D Molecular Therapeutics is (3.98 - 4.38), which suggest 4D Molecular Therapeutics is a Buy
-
The Bollinger Bands (100) for 4D Molecular Therapeutics is (3.2 - 4.3), which suggest 4D Molecular Therapeutics is a Buy
* 4D Molecular Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.